Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announces it has completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). Headquartered in Tampa, Florida, Acentus reports annual revenue of approximately $35 million. The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company’s strategic commitment to the homecare medical supplies market.
Read the full article: Henry Schein Completes Acquisition of Acentus //
Source: https://www.businesswire.com/news/home/20250114760320/en/Henry-Schein-Completes-Acquisition-of-Acentus